Latest Market News

North Stawell Minerals (ASX – NSM) reports promising drilling results and a robust project pipeline at its North Stawell Gold Project, highlighting shallow, high-grade gold mineralisation analogous to the nearby Stawell Gold Mine.

Peak Rare Earths shareholders have overwhelmingly approved Shenghe Resources’ acquisition scheme, setting the stage for imminent court approval and a cash payout.

Fat Prophets Global Contrarian Fund has successfully closed its Share Purchase Plan, raising nearly $1 million from existing shareholders. The capital injection will see over 740,000 new shares issued at a modest discount.

AMP Limited has announced a quarterly distribution of AUD 1.8508 per AMP Capital Notes 2 security, payable in December 2025, reflecting a partly franked yield based on current market rates.

Mad Paws Holdings has secured Foreign Investment Review Board approval for Rover Group’s full acquisition scheme, with the board unanimously recommending shareholder support.

Cobalt Blue Holdings has secured a crucial works approval for its Kwinana Cobalt Refinery, pushing Australia’s first dedicated cobalt processing plant closer to a final investment decision by the end of 2025.

Tivan Limited has agreed to acquire full ownership of the Molyhil Tungsten-Molybdenum Project, positioning itself at the forefront of critical minerals development in Australia's Northern Territory. This strategic move complements its adjacent Sandover Fluorite Project, promising operational synergies and accelerated growth.

IPH Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.195 per share and setting the Dividend Reinvestment Plan price at AUD 4.21 per share.

333D Limited has had its trading suspension lifted following a capital raise announcement and response to an ASX price query, signaling renewed market activity.

333D Limited has confirmed a $1 million placement to fund significant upgrades to its digital asset management platform, explaining a recent sharp rise in its share price and trading volume.

333D Limited has secured $1 million through a share placement to fund significant upgrades to its digital asset management platform, opting to preserve its Bitcoin holdings despite unbudgeted development costs.

Nyrada Inc. has released compelling preclinical data showing its drug candidate Xolatryp protects mitochondrial function by reducing calcium overload in brain injury models, bolstering confidence ahead of its Phase IIa trial in acute myocardial infarction.